Lawrence Schimmel - 02 Apr 2022 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role: Chief Medical Information Off
Signature: /s/ Lawrence Schimmel
Issuer symbol: NUTX
Transactions as of: 02 Apr 2022
Net transactions value: -$3,037,489,436
Form type: 4
Filing time: 02 Aug 2022, 14:26:00 UTC
Previous filing: 08 Apr 2022
Next filing: 04 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUTX	Common Stock	Conversion of derivative security	$30,375	+19,597	+8.4%	$1.55	253,645	02 Apr 2022	Direct
transaction	NUTX	Common Stock	Exercise of in-the-money or at-the-money derivative security	$15,188	+9,799	+3.9%	$1.55	263,444	02 Apr 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUTX	Convertible Promissory Note	Conversion of derivative security	$3,037,535,000	-30,375	-100%	$100000.00^*	0	02 Apr 2022	Common Stock	19,597	$1.55	Direct	F1
transaction	NUTX	Warrant	Exercise of in-the-money or at-the-money derivative security	$0	-9,799	-100%	$0.000000^*	0	02 Apr 2022	Common Stock	9,799	$1.55	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.
F2	Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.